Carregant...
Thr90Ser mutation in antithrombin is associated with recurrent thrombosis in a heterozygous carrier
Antithrombin (AT) is a serine protease inhibitor that regulates the activity of coagulation proteases of both intrinsic and extrinsic pathways. We identified an AT-deficient patient with a heterozygous Thr90Ser (T90S) mutation who experiences recurrent venous thrombosis. To understand the molecular...
Guardat en:
| Publicat a: | Thromb Haemost |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444675/ https://ncbi.nlm.nih.gov/pubmed/32422680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1710590 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|